Wilson Cook Medical Incorporated
$646.8K 196 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Novo Nordisk Health Care AG
Novo Nordisk Health Care AG reported $647,632.72 across General Payments, Research, and Ownership to 208 physicians and teaching hospitals across 248 transactions.
- $647.6K Above-median payer
- All-tracks total
- 248 Above-median volume
- Transactions
- 208 Above-median reach
- Recipients
- +$122.2K
- General Payments vs PY2023
Novo Nordisk Health Care AG reported $647,632.72 across all CMS Open Payments tracks (General + Research + Ownership) to 208 physicians and teaching hospitals in Program Year 2024 - ranking #709 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $441,969.99, averaging $3.1K per recipient.
How Novo Nordisk Health Care AG's $647.6K all-tracks total breaks down
Novo Nordisk Health Care AG's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
26/100
Total payments
F
16/100
Transaction volume
F
12/100
Physician reach
F
12/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer novo-nordisk-health-care-ag Novo Nordisk Health Care AG
$647.6K · #709/1,925 · 0.0% industry · PY2024
- TOT $647.6K
- RANK #709
- SHARE 0.0%
- TXN 248
- RCP 208
- CAT 5
- GEN $442.0K
- ΔGEN +$122.2K
- TOP1 17.1%
- PY 2024
Volume peers
Nearest volume peer: Wilson Cook Medical Incorporated ($646.8K)
Novo Nordisk Health Care AG sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Novo Nordisk Health Care AG's CMS-reported General Payments increased by $122.2K (+38.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: NOVO NORDISK HEALTH CARE AGPY2023: NOVO NORDISK HEALTH CARE AGPY2024: Novo Nordisk Health Care AG. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $319,766.23
- PY2024
- $441,969.99
What the Data Shows for Novo Nordisk Health Care AG
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Novo Nordisk Health Care AG, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $281.9K, accounting for 63.8% of this company's General Payments and 79 transactions.
General Payment Breakdown by Type
Novo Nordisk Health Care AG made 5 types of general payments. "Consulting Fee" is the largest category at $281.9K, 63.8% of General Payments.
Novo Nordisk Health Care AG reports 5 general-payment categories - the top three are Consulting Fee (63.8%), Travel and Lodging (28.5%), and Royalty or License (5.3%). The remaining 2 categories make up 2.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Novo Nordisk Health Care AG divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $281.9K | 79 | 63.8% |
| Travel and Lodging | $126.0K | 50 | 28.5% |
| Royalty or License | $23.5K | 7 | 5.3% |
| Food and Beverage | $8.9K | 70 | 2.0% |
| Compensation for Services Other Than Consulting | $1.7K | 2 | 0.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $219,692.12 (49.7%) of $441,969.99 in this company's General Payments records across 87 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Novo Nordisk Health Care AG
The five named recipients with the highest reported General Payments from this company
- 1
Enrico M Novelli
$75,710.66 across 16 reported transactions
- 2
Maria Fleseriu
$51,894.31 across 18 reported transactions
- 3
Allison Paroskie Wheeler
$45,907.92 across 12 reported transactions
- 4
Board Of Trustees Of The University
$23,483.45 across 7 reported transactions
- 5
Shlomo Melmed
$22,695.78 across 8 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Novo Nordisk Health Care AG ranks #709 of 1,925 by total payments (top 37% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,152 of 1,838 by HHI (bottom 37% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Convergent Dental Inc. : $901.1K total payments, HHI 756
- Cambridge Interventional LLC : $66.1K total payments, HHI 756
- Exelixis Inc. : $4.0M total payments, HHI 755
- Barco, Inc. : $175.3K total payments, HHI 752
- Urogen Pharma, Inc. : $1.6M total payments, HHI 751
- CapsoVision, Inc. : $966.0K total payments, HHI 748
- Novo Nordisk Health Care AG (this company) : $442.0K total payments, HHI 746
- McKesson Medical-Surgical Minnesota Supply, Inc : $837.57 total payments, HHI 746
- CTL Medical Corporation : $565.3K total payments, HHI 745
- Uswm, LLC : $57.8K total payments, HHI 743
- Tokuyama Dental America Inc. : $79.2K total payments, HHI 733
- Samsung Bioepis Co., Ltd. : $85.2K total payments, HHI 728
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Novo Nordisk Health Care AG's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Novo Nordisk Health Care AG.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Novo Nordisk Health Care AG.
Showing 6 of 1,924 companies with CMS-reported payment data.
Seigla Medical, Inc.
$651.1K 12 recipients
Compare payment profiles
Carlsmed, Inc.
$643.5K 1,199 recipients
Compare payment profiles
Volta Medical Inc
$643.0K 264 recipients
Compare payment profiles
Canon Medical Systems USA, Inc.
$640.6K 560 recipients
Compare payment profiles
Edap Technomed Inc
$640.3K 2,475 recipients
Compare payment profiles
Put this to use
Novo Nordisk Health Care AG ranks #709 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Novo Nordisk Health Care AG. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.